Cormorant Asset Management, LP

Holdings History for ROCKET PHARMACEUTICALS, INC. - Common stock, $0.01 par value per share (RCKT)

Symbol: RCKT on Nasdaq
Investment type: Equity / Common stock, $0.01 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Jun 2024		-0.36%	$0	0	-300,000	-100%	$3.48	Q2 2024
31 Mar 2024	0.36%	-0.18%	$8,082,000	300,000	-150,000	-33%	$26.94	Q1 2024
31 Dec 2023	0.65%	0%	$13,486,500	450,000	0		$29.97	Q4 2023
30 Sep 2023	0.54%	-0.5%	$9,220,500	450,000	-418,550	-48%	$20.49	Q3 2023
30 Jun 2023	0.98%	0%	$17,258,089	868,550	0		$19.87	Q2 2023
31 Mar 2023	0.98%	0%	$14,878,000	868,550	0		$17.13	Q1 2023
31 Dec 2022	1.1%	0%	$16,998,000	868,550	0		$19.57	Q4 2022
30 Sep 2022	0.98%	0%	$13,862,000	868,550	0		$15.96	Q3 2022
30 Jun 2022	0.93%	0%	$11,951,000	868,550	0		$13.76	Q2 2022
31 Mar 2022	1.1%	0%	$13,775,000	868,550	0		$15.86	Q1 2022
31 Dec 2021	1.1%	-0.13%	$18,960,000	868,550	-100,000	-10%	$21.83	Q4 2021
30 Sep 2021	1.2%	0%	$28,950,000	968,550	0		$29.89	Q3 2021
30 Jun 2021	1.7%	-0.69%	$42,897,000	968,550	-400,000	-29%	$44.29	Q2 2021
31 Mar 2021	1.7%	0%	$60,723,000	1,368,550	0		$44.37	Q1 2021
31 Dec 2020	2.2%	0%	$75,051,000	1,368,550	0		$54.84	Q4 2020
30 Sep 2020	1.4%	-0.1%	$31,285,000	1,368,550	-100,000	-6.8%	$22.86	Q3 2020
30 Jun 2020	1.3%	-0.09%	$30,737,000	1,468,550	-100,000	-6.4%	$20.93	Q2 2020
31 Mar 2020	1.2%	-0.21%	$21,881,000	1,568,550	-268,719	-15%	$13.95	Q1 2020
31 Dec 2019	1.8%	-0.29%	$41,816,000	1,837,269	-286,491	-13%	$22.76	Q4 2019
30 Sep 2019	1.8%	+0.04%	$24,742,000	2,123,760	+49,165	+2.4%	$11.65	Q3 2019
30 Jun 2019	2%	+0.36%	$31,119,000	2,074,595	+374,595	+22%	$15.00	Q2 2019
31 Mar 2019	2.1%	-0.31%	$29,818,000	1,700,000	-245,659	-13%	$17.54	Q1 2019
31 Dec 2018	2.6%	+0.6%	$28,835,000	1,945,659	+445,000	+30%	$14.82	Q4 2018
30 Sep 2018	2.6%	-0.03%	$36,946,000	1,500,659	-19,231	-1.3%	$24.62	Q3 2018
30 Jun 2018	2.4%	-0%	$29,835,000	1,519,890	-1	-0%	$19.63	Q2 2018
31 Mar 2018	2.5%	+2.5%	$28,498,000	1,519,891	+1,519,891	NEW	$18.75	Q1 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.